Lupus nephritis
Lupus nephritis (LN) is a form of glomerulonephritis that constitutes one of the most severe
organ manifestations of the autoimmune disease systemic lupus erythematosus (SLE). Most …
organ manifestations of the autoimmune disease systemic lupus erythematosus (SLE). Most …
Pre-eclampsia
EAP Steegers, P Von Dadelszen, JJ Duvekot… - The lancet, 2010 - thelancet.com
Pre-eclampsia remains a leading cause of maternal and perinatal mortality and morbidity. It
is a pregnancy-specific disease characterised by de-novo development of concurrent …
is a pregnancy-specific disease characterised by de-novo development of concurrent …
Screening for preeclampsia: US preventive services task force recommendation statement
K Bibbins-Domingo, DC Grossman, SJ Curry, MJ Barry… - Jama, 2017 - jamanetwork.com
Importance Preeclampsia affects approximately 4% of pregnancies in the United States. It is
the second leading cause of maternal mortality worldwide and may lead to serious maternal …
the second leading cause of maternal mortality worldwide and may lead to serious maternal …
Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study
LC Chappell, S Duckworth, PT Seed, M Griffin… - Circulation, 2013 - Am Heart Assoc
Background—Hypertensive disorders of pregnancy are a major contributor to death and
disability for pregnant women and their infants. The diagnosis of preeclampsia by using …
disability for pregnant women and their infants. The diagnosis of preeclampsia by using …
The global impact of pre-eclampsia and eclampsia
L Duley - Seminars in perinatology, 2009 - Elsevier
Over half a million women die each year from pregnancy related causes, 99% in low and
middle income countries. In many low income countries, complications of pregnancy and …
middle income countries. In many low income countries, complications of pregnancy and …
Pre-eclampsia: pathophysiology, diagnosis, and management
J Uzan, M Carbonnel, O Piconne, R Asmar… - Vascular health and …, 2011 - Taylor & Francis
The incidence of pre-eclampsia ranges from 3% to 7% for nulliparas and 1% to 3% for
multiparas. Pre-eclampsia is a major cause of maternal mortality and morbidity, preterm …
multiparas. Pre-eclampsia is a major cause of maternal mortality and morbidity, preterm …
Antiplatelet agents for preventing pre‐eclampsia and its complications
L Duley, S Meher, KE Hunter… - … of systematic reviews, 2019 - cochranelibrary.com
Background Pre‐eclampsia is associated with deficient intravascular production of
prostacyclin, a vasodilator, and excessive production of thromboxane, a vasoconstrictor and …
prostacyclin, a vasodilator, and excessive production of thromboxane, a vasoconstrictor and …
First‐trimester uterine artery Doppler and adverse pregnancy outcome: a meta‐analysis involving 55 974 women
L Velauthar, MN Plana, M Kalidindi… - … in Obstetrics & …, 2014 - Wiley Online Library
Objectives To determine the accuracy with which uterine artery Doppler in the first trimester
of pregnancy predicts pre‐eclampsia and fetal growth restriction, particularly early‐onset …
of pregnancy predicts pre‐eclampsia and fetal growth restriction, particularly early‐onset …
Early pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers: the Screening for Pregnancy Endpoints (SCOPE) …
More than half of all cases of preeclampsia occur in healthy first-time pregnant women. Our
aim was to develop a method to predict those at risk by combining clinical factors and …
aim was to develop a method to predict those at risk by combining clinical factors and …
Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms‐like tyrosine kinase 1 and soluble endoglin in the prediction of pre …
CE Kleinrouweler, MMJ Wiegerinck… - … Journal of Obstetrics …, 2012 - Wiley Online Library
Please cite this paper as: Kleinrouweler C, Wiegerinck M, Ris‐Stalpers C, Bossuyt P, van
der Post J, von Dadelszen P, Mol B, Pajkrt E, for the EBM CONNECT Collaboration …
der Post J, von Dadelszen P, Mol B, Pajkrt E, for the EBM CONNECT Collaboration …